-The Hindustan Times There is a widespread perception of policy paralysis in the corridors of power. The two remaining years of the UPA's term is still not too short to reverse the current drift, but time is rapidly running out. The damaged economy needs urgent fixing as does restoring the credibility of an executive racked by scandals and the absence of a sense of direction. The people of the country long...
More »SEARCH RESULT
Aamir presents plan for better healthcare-Chetan Chauhan
-The Hindustan Times Bollywood star Aamir Khan had two simple prescriptions for a Parliamentary committee to reduce high health costs for citizens. First, make doctors prescribe generic medicines rather than brands. Second, set up a regulator to ensure big pharmaceutical don’t take over smaller ones and monopolise the medicine market. Khan and his team were invited on Thursday by the Parliamentary Standing Committee on Commerce headed by BJP MP Shanta Kumar, which...
More »ACTA will make life saving drugs costlier for the poor-Rachit Ranjan
Joseph Munyi, a Kenyan citizen, has been living with HIV for 8 years and, much like other HIV patients, is unemployed. He has been receiving his medication free of charge on account of government programmes and outreach programmes of Medicine Sans Frontieres. His medication comes in the form of generic drugs. However, this situation may not last long as economic interests of few may end up impeding many a public spirited...
More »How PH Kurien took on global patents system to make very costly drug affordable for poor-Arvind Panagariya
It is said that only God and a few good men and women run India. One such man is P H Kurien. For readers unfamiliar with his name, Kurien was India's Controller General of Patents, Designs & Trade Marks until March 12, 2012. On March 9, 2012, just three days before he left office, he issued the first-ever compulsory licence in India for the manufacture of a drug still under patent....
More »The government needs to think out of the box to help pharma grow while keeping medicines affordable-Ramesh Adige
Having watched from the ringside for many years now, I have no doubt in advising that the steering wheel must be firmly grasped by the government and direction given to policies that should be stable for at least the medium term. This is crucial for the growth of Indian pharma, a $20-billion industry growing at an average of 12% considering both domestic and export arenas. Price control: The biggest and most...
More »